GRTX - Galera Therapeutics: Trial Reversal Did Not Take The Stock Higher December, 24 2021 01:29 PM Galera Therapeutics Inc. In October, GRTX announced that its phase 3 trial failed. In December, GRTX said the trial had actually succeeded. The stock tanked in October, then recovered in December, but not by as much. For further details see: Galera Therapeutics: Trial Reversal Did Not Take The Stock Higher